Home  /  Resource Library  /  Antibiotic Therapy and Low Gut Microbiome Diversity Is Associated with Decreased Response and High Toxicity in BCP-ALL and DLBCL Patients after Treatment with CD19 CAR T-Cells

Antibiotic Therapy and Low Gut Microbiome Diversity Is Associated with Decreased Response and High Toxicity in BCP-ALL and DLBCL Patients after Treatment with CD19 CAR T-Cells

ASH 2020: Study examined the association of the gut microbiome and response and toxicity to CAR T-cell therapy.